Ahrens Investment Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-100
Closed -$8K 249
2022
Q2
$8K Hold
100
﹤0.01% 676
2022
Q1
$8K Sell
100
-100
-50% -$8K ﹤0.01% 761
2021
Q4
$18K Buy
+200
New +$18K 0.01% 597